IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,871,946 | -6.7% | 901,057 | -15.6% | 0.01% | 0.0% |
| Q2 2023 | $43,808,674 | +15.9% | 1,067,723 | +1.0% | 0.01% | 0.0% |
| Q1 2023 | $37,791,394 | +103019.9% | 1,057,395 | +9.0% | 0.01% | 0.0% |
| Q4 2022 | $36,648 | -99.9% | 970,310 | +4.5% | 0.01% | -16.7% |
| Q3 2022 | $41,079,000 | +6.7% | 928,752 | -10.7% | 0.01% | +20.0% |
| Q2 2022 | $38,484,000 | -12.1% | 1,039,570 | -12.0% | 0.01% | 0.0% |
| Q1 2022 | $43,765,000 | +13.4% | 1,181,557 | -6.9% | 0.01% | +25.0% |
| Q4 2021 | $38,605,000 | -52.4% | 1,268,652 | -47.5% | 0.00% | -60.0% |
| Q3 2021 | $81,044,000 | -10.7% | 2,416,313 | +6.2% | 0.01% | -9.1% |
| Q2 2021 | $90,778,000 | +2.8% | 2,275,706 | +15.9% | 0.01% | -8.3% |
| Q1 2021 | $88,266,000 | -16.7% | 1,963,223 | +4.8% | 0.01% | -25.0% |
| Q4 2020 | $105,918,000 | +200.1% | 1,873,332 | +157.4% | 0.02% | +166.7% |
| Q3 2020 | $35,290,000 | +15.5% | 727,929 | +40.5% | 0.01% | 0.0% |
| Q2 2020 | $30,551,000 | +137.8% | 518,169 | +90.7% | 0.01% | +100.0% |
| Q1 2020 | $12,847,000 | -60.4% | 271,722 | -49.4% | 0.00% | -50.0% |
| Q4 2019 | $32,437,000 | +151.5% | 536,951 | +149.4% | 0.01% | +100.0% |
| Q3 2019 | $12,899,000 | +11.6% | 215,291 | +20.5% | 0.00% | +50.0% |
| Q2 2019 | $11,562,000 | +1082.2% | 178,738 | +1384.3% | 0.00% | – |
| Q1 2019 | $978,000 | -87.8% | 12,042 | -91.9% | 0.00% | -100.0% |
| Q4 2018 | $8,037,000 | +1385.6% | 148,658 | +1318.9% | 0.00% | – |
| Q3 2018 | $541,000 | +12.7% | 10,477 | -9.0% | 0.00% | – |
| Q2 2018 | $480,000 | +100.0% | 11,514 | +111.0% | 0.00% | – |
| Q1 2018 | $240,000 | -92.3% | 5,456 | -91.2% | 0.00% | -100.0% |
| Q4 2017 | $3,124,000 | -5.1% | 62,107 | -0.7% | 0.00% | 0.0% |
| Q3 2017 | $3,292,000 | +3478.3% | 62,572 | +3358.9% | 0.00% | – |
| Q2 2017 | $92,000 | +148.6% | 1,809 | +97.7% | 0.00% | – |
| Q1 2017 | $37,000 | -39.3% | 915 | -28.2% | 0.00% | – |
| Q4 2016 | $61,000 | -65.5% | 1,275 | -73.5% | 0.00% | – |
| Q3 2016 | $177,000 | -84.1% | 4,818 | -90.0% | 0.00% | – |
| Q2 2016 | $1,116,000 | +222.5% | 47,959 | +461.6% | 0.00% | – |
| Q1 2016 | $346,000 | +181.3% | 8,539 | +327.0% | 0.00% | – |
| Q4 2015 | $123,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |